{"id":"https://genegraph.clinicalgenome.org/r/b2b3e8a3-2edf-4c71-9a0c-ba086b1f4398v1.2","type":"EvidenceStrengthAssertion","dc:description":["*SMARCA5* encodes the ATPase motor of the ISWI chromatin remodeler. *SMARCA5* was first reported in relation to autosomal dominant complex neurodevelopmental disorder in 2021 (Li et al., PMID: 33980485). Affected individuals exhibit mild developmental delay, intellectual disability (in 50%), failure to thrive, postnatal microcephaly, short stature, mild dysmorphic facial features and mild skeletal and limb abnormalities (PMID: 33980485). Other less frequent features may include hypotonia, behavioral abnormalities, and seizures.  \n\nNine variants (7 missense and 2 in-frame deletions) reported in 10 probands in one publication (PMID: 33980485) are included in this curation. Most reported variants occur *de novo*. One variant is recurrent (p.Ile434_Leu435del), and several variants are located within or around the helicase domains. The mechanism of pathogenicity appears to be partial loss of function, based on the study of a missense variant and an in-frame variant in a Drosophila model (PMID: 33980485).\n\nThis gene-disease relationship is also supported by experimental evidence, including a non-mammalian model system, biochemical function and protein interactions. Neuro-specific knockdown of *Iswi*, the *SMARCA5* ortholog in Drosophila, led to smaller brain size, structural deficits of the mushroom body, and impaired motor function (PMID: 33980485). Another member of the ISWI complex, BPTF, has been shown to interact with SMARCA5 (PMID: 22729083) and is involved in a neurodevelopmental disorder with overlapping features.\n\nIn summary, there is moderate evidence supporting the relationship between *SMARCA5* and autosomal dominant complex neurodevelopmental disorder. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on June 18, 2025 (SOP Version 11).\n","*SMARCA5* encodes the ATPase motor of the ISWI chromatin remodeler. *SMARCA5* was first reported in relation to autosomal dominant complex neurodevelopmental disorder in 2021 (Li et al., PMID: 33980485). Affected individuals exhibit mild developmental delay, intellectual disability (in 50%), failure to thrive, postnatal microcephaly, short stature, mild dysmorphic facial features and mild skeletal and limb abnormalities (PMID: 33980485). Other less frequent features may include hypotonia, behavioral abnormalities, and seizures.  \n\n\nNine variants (7 missense and 2 in-frame deletions) reported in 10 probands in one publication (PMID: 33980485) are included in this curation. Most reported variants occur de novo. One variant is recurrent (p.Ile434_Leu435del), and several variants are located within or around the helicase domains. The mechanism of pathogenicity appears to be partial loss of function, based on the study of a missense variant and an in-frame variant in a Drosophila model (PMID: 33980485).\n\n\nThis gene-disease relationship is also supported by experimental evidence, including a non-mammalian model system, biochemical function and protein interactions. Neuro-specific knockdown of *Iswi*, the *SMARCA5* ortholog in Drosophila, led to smaller brain size, structural deficits of the mushroom body, and impaired motor function (PMID: 33980485). Another member of the ISWI complex, BPTF, has been shown to interact with SMARCA5 (PMID: 22729083) and is involved in a neurodevelopmental disorder with overlapping features.\n\n\nIn summary, there is moderate evidence supporting the relationship between *SMARCA5* and autosomal dominant complex neurodevelopmental disorder. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panels on June 18, 2025 (SOP Version 11).\n"],"dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/b2b3e8a3-2edf-4c71-9a0c-ba086b1f4398","GCISnapshot":"https://genegraph.clinicalgenome.org/r/b1941d78-2658-4c23-b512-985234d7b4dc","calculatedEvidenceStrength":"Moderate","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/b1941d78-2658-4c23-b512-985234d7b4dc_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":["2025-06-18T19:00:00.000Z","2025-06-18T10:00:00.000Z"],"role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/b1941d78-2658-4c23-b512-985234d7b4dc_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2025-09-08T21:40:44.783Z","role":"Publisher"}],"curationReasons":["ErrorClarification"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b1941d78-2658-4c23-b512-985234d7b4dc_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d180f46f-4cad-40df-a7e9-2e903c34e315","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d180f46f-4cad-40df-a7e9-2e903c34e315_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33980485","allele":{"id":"https://genegraph.clinicalgenome.org/r/f89bee91-1032-4689-87af-c9df4590860e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003601.4(SMARCA5):c.2207G>A (p.Arg736Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA358339690"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/4212ddd9-c79d-40e4-a7c2-5e1b88440517","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4212ddd9-c79d-40e4-a7c2-5e1b88440517_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33980485","allele":{"id":"https://genegraph.clinicalgenome.org/r/898bcdf7-a571-4cb7-9577-4bc12a2a8b9f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003601.4(SMARCA5):c.2677G>A (p.Glu893Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA358344354"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/c4274b87-cc0c-40c5-ac9f-76978f522b86","type":"EvidenceLine","dc:description":"Recurrent variant;reported in Li Proband 9.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c4274b87-cc0c-40c5-ac9f-76978f522b86_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33980485","allele":{"id":"https://genegraph.clinicalgenome.org/r/d8a70f9c-8145-4537-98e3-d24d1c89bff2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003601.4(SMARCA5):c.1301_1306del (p.Ile434_Leu435del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA658789161"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/4f883c03-c4c8-48b6-ac54-366d8c932ef8","type":"EvidenceLine","dc:description":"Not scored. Mother and maternal grandmother are also heterozygous for this variant but the degree of their neurodevelopmental delay was not assessed.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4f883c03-c4c8-48b6-ac54-366d8c932ef8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33980485","allele":{"id":"https://genegraph.clinicalgenome.org/r/aca20724-af50-4bd0-99e8-f7fc018ee7d4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003601.4(SMARCA5):c.1711G>C (p.Ala571Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA358336160"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/b5164096-440c-4d63-8274-537fcf884878","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b5164096-440c-4d63-8274-537fcf884878_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33980485","allele":{"id":"https://genegraph.clinicalgenome.org/r/8dc05101-f30c-4879-bc53-477a0feeaa4b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003601.4(SMARCA5):c.1130A>T (p.Asp377Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA358331224"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/f658daff-b83d-4165-97d3-730908339840","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f658daff-b83d-4165-97d3-730908339840_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33980485","allele":{"id":"https://genegraph.clinicalgenome.org/r/88884ab7-4324-4e66-b129-a548e05e10b1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003601.4(SMARCA5):c.802-2A>G","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA358328997"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/f658daff-b83d-4165-97d3-730908339840_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Exon 7 skipping confirmed by RT-PCR of probandâ€™s fibroblasts and LCL. SMARCA5 268-319del partially rescued Iswi2 larval body size but did not rescue cellular proliferation, and the tiling phenotype, demonstrating that this variant leads to a partial loss of function of brain/neuronal cells.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/44a3493f-0a3f-4c9c-a3fb-46a1cbfd48b6","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/44a3493f-0a3f-4c9c-a3fb-46a1cbfd48b6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33980485","allele":{"id":"https://genegraph.clinicalgenome.org/r/0a4cf8ed-1176-4a9c-a831-177c23366678","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003601.4(SMARCA5):c.1775G>A (p.Arg592Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA358336757"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/44a3493f-0a3f-4c9c-a3fb-46a1cbfd48b6_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"SMARCA5-R592Q partially rescued Iswi2 larval body size but did not rescue cellular proliferation, and the tiling phenotype, demonstrating that these two variants led to a partial loss of function of brain/neuronal cells.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/10ad4314-c531-4804-83b6-911dffa70bfa","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/10ad4314-c531-4804-83b6-911dffa70bfa_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33980485","allele":{"id":"https://genegraph.clinicalgenome.org/r/febb9e14-dc2d-484e-ad92-7d58ccba07e9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003601.4(SMARCA5):c.1682C>A (p.Ala561Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA358335976"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/113b4fe2-cf74-498d-acfb-efb62c3be140","type":"EvidenceLine","dc:description":"Recurrent variant; reported in Li Proband 3.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/113b4fe2-cf74-498d-acfb-efb62c3be140_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33980485","allele":{"id":"https://genegraph.clinicalgenome.org/r/d8a70f9c-8145-4537-98e3-d24d1c89bff2"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/ef8f9040-076d-426b-9b97-cf6822b4a3fe","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ef8f9040-076d-426b-9b97-cf6822b4a3fe_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33980485","allele":{"id":"https://genegraph.clinicalgenome.org/r/296e40b7-a885-47bd-8d33-c100d0cdd468","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003601.4(SMARCA5):c.1855G>C (p.Glu619Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA358337197"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":5.5},{"id":"https://genegraph.clinicalgenome.org/r/b1941d78-2658-4c23-b512-985234d7b4dc_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b1941d78-2658-4c23-b512-985234d7b4dc_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ea31219e-17d4-4d1f-add1-9a0e15ddcd54","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/59a7c61a-4aef-4b97-953b-a9d55faffde9","type":"Finding","dc:description":"SMARCA5 was shown to co-immunoprecipitate with BPTF in primary human epidermal stem cells. BPTF is involved in a neurodevelopmental disorder with overlapping features.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22729083","rdfs:label":"SMARCA5 interacts with BPTF","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/f4fc2375-bda0-4492-b6a6-65aaf9dac9cb","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a854c444-9139-4781-86f2-448e7459a7c5","type":"Finding","dc:description":"Another member of the ISWI family of chromatin remodeling complexes, BPTF, is associated with a neurodevelopmental disorder with speech delay, postnatal microcephaly, distal anomalies, and dysmorphic features. Furthermore, other genes encoding chromatin remodelers and associated subunits have been involved in neurodevelopmental disorders, including the SWI/SNF subunits ARID1A, ARID1B, ARID2, SMARCA4, SMARCB1, SMARCE1, SMARCD1, SMARCC2, DPF2, BICRA, SMARCA2, BCL11A, ACTL6B, ACTB, and ACTG1; and the CHD (chromatin helicase DNA binding) subunits CHD3, CHD4, CHD7, and CHD8. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33980485","rdfs:label":"ISWI chromatin remodeling complex","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/b1941d78-2658-4c23-b512-985234d7b4dc_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b909aaf8-f01f-4478-947d-88208d3e383d","type":"EvidenceLine","dc:description":"Score downgraded because the model is a non-mammalian species.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/46f205a1-e245-4279-9c7e-aaad6ebdaf86","type":"Finding","dc:description":"Loss of function of the Drosophila gene Iswi, which is orthologous to human SMARCA1 or SMARCA5, led to death before the end of the larval stage. Larvae that survived to third instar had smaller body size and reduced dendrite arborization in sensory neurons. Neuro-specific knockdown of Iswi induced by RNAi-1 led to smaller brain sizes, structural deficits of the mushroom body (learning and memory center of the fly), and abnormal locomotor function in adult flies. Iswi loss of function was rescued by wild-type but not mutant SMARCA5. Gong et al. (2021, PMID 33597246) reported that Iswi knockdown in flies leads to mushroom morphological abnormalities, disrupted sleep, circadian rhythmicity, memory, and social behaviors suggesting that Iswi is required during development for numerous adult behaviors. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33980485","rdfs:label":"Neuro-specific knockdown of Iswi in flies","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":1.5}],"evidenceStrength":"Moderate","sequence":11635,"specifiedBy":"GeneValidityCriteria11","strengthScore":7,"subject":{"id":"https://genegraph.clinicalgenome.org/r/Os9-pVMgiiQ","type":"GeneValidityProposition","disease":"obo:MONDO_0100038","gene":"hgnc:11101","modeOfInheritance":"obo:HP_0000006"},"version":"1.2","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_b1941d78-2658-4c23-b512-985234d7b4dc-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}